Loading...
The Financial Express
Swasti Lankabangla Swasti Lankabangla

Health

Sanofi, GSK to supply 200m vaccine doses to WHO-backed alliance

French drugmaker Sanofi and Britain's GlaxoSmithKline (GSK) will supply 200 million doses of their COVID-19 candidate vaccine to a global initiative to ensure equitable distribution backed by the World Health Organization. There is no internationally-approved treatment against COVID-19, which has...

12 new dengue cases registered

Twelve new dengue cases were reported in the last 24...

‘Consider all evidences, including trial flop, before approving remdesivir’

Health officials reviewing Gilead Science Inc's remdesivir against COVID-19 should...

Gilead's remdesivir gets US approval to treat hospitalised Covid patients

The US Food and Drug Administration on Thursday approved Gilead...

EU urges WHO to change handling of pandemic

The European Union wants the World Health Organisation to become...

Scientists detect possible new organ in human throat

Dutch scientists have claimed that they have found a potential...

Brazil volunteer in AstraZeneca’s Covid-19 vaccine trial dies

Brazilian health authority Anvisa said on Wednesday that a volunteer...

3.0b people likely to have no access to Covid-19 vaccine

From factory to syringe, the world’s most promising coronavirus vaccine...

China's Sinovac vaccine is safe, Brazil institute comments

An experimental coronavirus vaccine developed by China's Sinovac Biotech appeared...

Britain to allow infecting volunteers in trials for Covid-19 vaccines

Britain said on Tuesday it would back “human challenge” trials,...

Hospitalised COVID-19 patients can have ongoing symptoms for months: Study

More than half of COVID-19 patients discharged from hospital still...

‘Coronavirus lives on human skin for 9 hours’

Japanese researchers in a study have found that the lethal...

Almost 80pc Bangladeshi hypertension patients receive care at private units: Study

More than 77-per cent hypertension patients receive treatment at private...

Russia's COVID-19 vaccine Sputnik V to undergo trial in India

Late-stage trials of Russia's COVID-19 vaccine Sputnik V will be...

Covid-19 can infect brain tissue, affect memory, language: Study

SARS-CoV-2, the virus that causes coronavirus, is capable of infecting...

Activists call for limiting trans fat to 2.0pc

Safe food activists have urged the authorities to craft policies...

WHO vaccine drive bedevilled by familiar question: who pays if things go wrong?

Who foots the bill if people in poor countries fall...

Policy sought to fix trans fat limit at 2.0pc

On the occasion of the World Food Day, advocacy group...

'Long COVID' may affect multiple parts of body and mind, doctors say

Ongoing illness after infection with COVID-19, sometimes called “long COVID”,...

Oxford scientists develop five-minute COVID-19 antigen test

Scientists from Britain's University of Oxford have developed a rapid...

40pc of world’s population lack handwashing facilities at home: UNICEF

Experts: Teach hygiene habits in early childhood

Why Bangladeshi children, women need special care during pandemic

Malnutrition could claim lives of more 10,000 children per month this year

Reinfection cases raise concerns over immunity

WHO calls herd immunity approach against Covid-19 'problematic'

Johnson & Johnson's Covid-19 vaccine trial halted after 'unexplained illness'

Johnson & Johnson said on Monday it had temporarily paused its Covid-19 vaccine candidate clinical trials due to an unexplained illness in a study participant, delaying one of the highest profile efforts to contain the global pandemic. The participant's illness is being reviewed and evaluated by an independent data and...

Pandemic can be overcome promptly with right tools : WHO

Covid-19 virus survives for 28 days on surfaces, scientists find

Seven new dengue cases reported in 24 hrs

© 2020 - All Rights with The Financial Express